n-Lorem Foundation and Columbia University Establish Silence ALS Initiative
Silence ALS initiative will offer [...]
n-Lorem Foundation Welcomes Amy McCooe to its Board of Directors
Amy McCooe’s leadership in integrating [...]
n-Lorem and The Wolverine Foundation Collaborate to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients
n-Lorem received a $3 million [...]
The Conrad Prebys Foundation to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients
n-Lorem awarded a $300,000 one-year [...]
La Jolla Labs and n-Lorem Foundation Partner to Discover Personalized ASO Medicines for Nano-rare Patients
Partnership leverages La Jolla Labs’ [...]
Second Anniversary for n-Lorem Foundation Marks Extraordinary Progress Toward Treating Nano-Rare Patients
n-Lorem’s donor and partner support [...]
Parexel and n-Lorem Foundation Partner to Support Development of New Investigational Therapies for Nano-rare Patients
Parexel to provide clinical operations, [...]
n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases
Cytiva donates equipment totaling $415,000 [...]
